Oxford, United Kingdom

Paul Laidler

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Laidler

Introduction

Paul Laidler is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of allergy treatment through his innovative research and development of peptides. With a total of 12 patents to his name, Laidler's work is at the forefront of medical advancements aimed at improving the quality of life for individuals suffering from allergies.

Latest Patents

Among his latest patents, Laidler has developed Cladosporium peptides, which are polypeptides designed to prevent or treat allergies to moulds of the genus Cladosporium. These peptides can have up to 30 amino acids in length and include specific amino acid sequences that are crucial for their effectiveness. Additionally, he has created a peptide composition for vaccines that targets allergies to house dust mites, focusing on optimal combinations of peptides to enhance treatment efficacy.

Career Highlights

Laidler's career is marked by his dedication to research and innovation in the field of allergy treatment. His work has led to the development of groundbreaking therapies that address common allergens, showcasing his commitment to improving patient outcomes. His extensive patent portfolio reflects his expertise and the impact of his inventions on the medical community.

Collaborations

Throughout his career, Laidler has collaborated with notable colleagues, including Roderick Peter Hafner and Mark Larche. These partnerships have fostered a collaborative environment that encourages the exchange of ideas

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…